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BACKGROUND: An altered compositional signature and reduced diversity of early gut 
microbiota are linked to development of allergic disease. We investigated the relationship 
between dominant Bifidobacterium species during early postnatal period and subsequent 
development of allergic disease in the first year of life.  
 
METHODS: Faecal samples were collected at age 1 week, 1 month and 3 months from 117 
infants at high risk of allergic disease. Bifidobacterium species were analysed by quantitative 
PCR and terminal restriction fragment length polymorphism. Infants were examined at 3, 6 
and 12 months, and skin prick test performed at 12 months. Eczema was diagnosed according 
to the UK-Working Party criteria.  
 
RESULTS: The presence of B. catenulatum at 3 months was associated with a higher risk of 
developing eczema (ORadj =4.5; 95% CI 1.56 to 13.05, padj =0.005). Infants colonised with 
B. breve at 1 week (ORadj =0.29; 95% CI 0.09 to 0.95, padj =0.04) and 3 months (ORadj 
=0.15; 95% CI 0.05 to 0.44, padj =0.00001) had a reduced risk of developing eczema. 
Furthermore, the presence of B. breve at 3 months was associated with a lower risk of atopic 
sensitisation at 12 months (ORadj =0.38; 95% CI 0.15 to 0.98, padj =0.05). B. breve 
colonisation patterns were influenced by maternal allergic status, household pets and number 
of siblings.  
 
CONCLUSIONS: Temporal variations in Bifidobacterium colonisation patterns early in life 
are associated with later development of eczema and/or atopic sensitisation in infants at high 
risk of allergic disease. Modulation of the early microbiota may provide a means to prevent 
eczema in high risk infants. This article is protected by copyright. All rights reserved. 
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